An experimental COVID-19 vaccine from Novavax appears to offer strong protection in late-stage UK, South Africa studies
AP
Posted:
Updated:
by
Rayos Syndication User
WASHINGTON (AP) — An experimental COVID-19 vaccine from Novavax appears to offer strong protection in late-stage UK, South Africa studies.
